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ABSTRACT
The oral cavity has been established as an entrance door and second ecological niche of Helicobacter pylori 
(HP). This question remains open – is the oral cavity a source of stomach infection or a cause of re-infection, 
recurrence or persistence of the infection? The aim of this study is to evaluate the frequency of HP infection 
into dental plaque and saliva on the base of performed screening, parallel and post-eradication investiga-
tion. In the context of this research the method of PCR has been implemented. In the course of the screening 
examination HP infection has been proved in 66% of all the cases. By the means of parallel investigation a 
combined infection has been confirmed in 62% of all the cases – presence of HP in the stomach and into the 
dental plaque. Concerning the HP infection into the dental plaque, it is in co-relation with both of the symp-
toms – periodontitis and halitosis. Taking into consideration these facts, we can conclude that oral cavity 
serves as a reservoir of infection, as well as a source for its tranfer into the stomach. Poor oral health status, 
including clinical findings of periodontitis and halitosis, have to be accepted as alarming markers for HP 
infection into the oral cavity and stomach. It is of great necessity for the patient to organize regular visits to 
the dentist for dental plaque control and tartar removal and maintenance of proper oral-dental condition as 
a measure of prevention of HP infection. 
Keywords: Helicobacter pylori infection, oral cavity, prevalence, PCR, dental plaque, combined HP 
infection
INTRODUCTION
Infection with Helicobacter Pylori is a very old, 
mass and widespread disease all over the world, af-
fecting over 50% of the world population. It is large-
scaled in the developing countries, at the same time 
characterized with lower distribution concerning the 
developed countries /its frequency rates at 25-40% in 
Western Europe, in our country it amounts to 80%/. 
The process of contamination is being performed 
during the first years after birth, transferred direct-
ly from the infected mother to the newly-born. This 
bacterium infects the macroorganism, provoking 
clinical manifestation only in 15-20% of the carriers. 
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Most of the infected are characterized by no symp-
toms. On the base of our previously performed inves-
tigation (1) there is a tendency of reduction of the dis-
tribution of HP infection among dyspeptic patients, 
totaling up to 15% today. It has been established that 
the infection with Helicobacter pylori plays the role 
of an etiological and pathogenic factor for initiation 
and progression of chronic gastritis, atrophic gastri-
tis, ulcer disease (gastric and duodenal ulcer), gastric 
cancer and MALT-lymphoma. In the year 1992 the 
infection was defined by the WHO as a cancerogenic 
agent of first class. For this reason it has been deter-
mined as a disease with social impact, associated 
with the progression of a significant socio-pathology 
with great public response. So, the strategy of testing 
for Helicobacter pylori and successful treatment is 
established as a step ahead concerning the preven-
tion of gastric cancer. The oral cavity is an entrance 
door for the infection and the main reservoir of He-
licobacter pylori out of the gastric (2), being a second 
ecological medium. It has been confirmed that by pa-
tients with dyspeptic complaints Н. pylori is record-
ed in 80% to 97% of all cases into the dental plaque 
and in 55% of all cases into saliva (3, 4). Gebara et al. 
(5) have reported that the concentration of H. pylo-
ri into the sub-gingival dental plaque is almost twice 
higher compared with that into supra-gingival one 
(amounting to 22%). According to Songet et al. (3) 
these bacteria predominantly inhabit periodontal 
pockets with deepness over 4 mm (57%), in compari-
son to pockets under 4mm (34%). There are investi-
gations about various rates of its distribution into the 
plaque on different teeth surfaces (3). The isolation of 
H. pylori in dental plaque has been recorded to be in-
termittent (6).
Taking into consideration the importance of 
oral cavity as a source of H. pylori infection and its 
role for re-infection of the stomach, we have deter-
mined these TASKS:
 ❖ To perform an investigation concerning ascer-
tainment of the bacterium of Н. pylori in the 
oral cavity (dental plaque and saliva) into var-
ious groups: screening, parallel to stomach ex-
amination and after HP eradication treatment;
 ❖ To investigate the co-relation between the pres-
ence of the Н. pylori bacterium in oral cavity 
and symptoms of clinical manifestation, as well 
as the combined infection in the oral cavity and 
stomach.
 ❖ To investigate the influence of the status of Н. 
pylori on the effect of eradication treatment.
CLINICAL MATERIAL AND 
METHODS
This study included 146 patients with a mean 
age of 49. In 111 of them the dental plaque, and in the 
other 35 – saliva has been examined for the presence 
of Н. pylori. The screening test of the dental plaque 
has been performed in 18 patients, chosen at random 
during dentists’ visits. In 58 patients a parallel inves-
tigation has been provided with confirmed HP infec-
tion in the stomach. In 31 patients the dental plaque 
has been examined after eradication treatment.
The oral-dental status of patients with diag-
nosed НР infection into the dental plaque has been 
estimated as well during screening tests. Examina-
tion of the teeth and other structures in the oral cav-
ity was conducted by dentist. The aim to obtain ad-
ditional information about clinical symptoms, an-
amnesis data of gastro-duodenal pathology and tests 
concerning the diagnosis of HP infection, is per-
formed by the application form and clinical card. 
We used a question form containing 10 “yes” or “no” 
questions. The clinical card has been provided to the 
dental specialist to register alterations of the oral sta-
tus. After accomplishment of the study the results 
have been summarized and analyzed.
Among the greater portion of patients a PCR 
test was conducted, a quality method for proof of НР 
– DNA into the dental plaque and saliva. A specif-
ic procedure for collection of biological material was 
applied. A small particle of purified dental plaque 
was taken (the procedure is conducted by dental spe-
cialist), put into 0.1 ml of sterile physiological solu-
tion, then transferred into the laboratory. Saliva – 
several drops were taken, equal to 1 volume, and add-
ed to 1 volume β-mercaptoethanol – 0.1 ml М.Vortex 
for incubation at room temperature for 30 minutes 
during stirring. 1.0 ml of the clinical material is put 
into a sterile propylene micro-tube, afterwards be-
ing centrifuge processed at the rate of 10 000 revolu-
tions per minute with duration of 10 minutes. A por-
tion of the supernatant was taken with a pipette and 
an amount of 100 μl provided for DNA extraction. 
For the purpose of DNA separation out of the clinical 
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material were applied 5 types of solution: 1- a lysis 
solution, 2- a solution for first irrigation, 3- a solution 
for second irrigation, 4- sorbent universal solution, 
5- buffer solution. During the process of centrifuging 
separation of the fluid containing DNA was provid-
ed. Four main processes were performed – extrac-
tion, amplification, detection by electrophoresis and 
photo-analysis. Positive and negative results were re-
corded. The method of One Step H. pylori Test Disk-
anti-gene test for proof of HP urease in saliva was 
applied. This is an immune-chromatographic ex-
amination for qualitative detection of urease with 
НР infection. The buffer solution is mixed with sev-
eral drops of saliva. A portion of the mixture (sali-
va/buffer) is put upon the test. The results are reg-
istered in the time interval between the 5th and 15th 
minute. The analytic sensitivity of the test amounts 
to 5 ng/ml. The appearance of a pink-red strip serves 
as a proof of a positive result. An essential require-
ment concerning the roper performance of the test is 
that the patient is not allowed to consume food and 
drinks for 1 hour before it. This method was applied 
in 35 patients, predominantly for infection monitor-
ing, after unsuccessful eradication.
Usually prescribed as a first choice of eradica-
tion therapy is the standard triple one: Proton pump 
inhibitor + Claritromycine + Amoxicilline/Tinida-
zole. Another option is a stage therapy pattern in-
cluding 2 consecutive stages with a duration of 5 days 
each:
1. Proton pump inhibitor + Amoxicilline for the 
first 5 days.
2. Proton pump inhibitor + Claritromycine + 
Tinidazole for the next 5 days.
A probiotic has also been applied – Lactobacillus 
reuteri (Bio Gaia). The concentration of lactic bacte-
ria in 1 tablet Bio Gaia equals to 100 million alive 
Lactobacillus reuteri bacteria in a dose; intake of 1 
tablet twice daily. Lactobacillus reuteri (Bio Gaia-pro 
dentis) with a local effect on the oral cavity has been 
applied, too.
RESULTS
Examination of НР by means of PCR into den-
tal plaque. 
The results of study for proving HP into dental 
plaque in the determined 3 groups are summarized 
and represented in table 1.
18 patients participated in the screening test. 
In 12 of them (66.7%) the result was positive, i.e. НР 
bacteria was present in the dental plaque.
In 58 patients with a parallel investigation for 
the presence of HP diagnosed infection in the stom-









Positive 12 36 13
Negative 6 22 18
Total 18 58 31
Table 1. Distribution according to НР status in dental 
plaque
  HP positive НР negative
p
Symptom n (%) n (%)
periodontitis 38 (82.6) 3 (37.5) 0.015*
bleeding 23 (51.1) 3 (33.3) 0.47
gum bleeding 16 (34.8) 1(12.5) 0.411
presence of dental plaque 45 (97.8) 6 (75.0) 0.054
decayed teeth 30 (65.2) 4 (50.0) 0.45
erosion on teeth cervices 15 (32.6) 4 (50.0) 0.431
tongue coating 6 (13.0) 2 (25.0) 0.588
aphthae 7 (15.6) 2 (25.0) 0.611
halitosis 41 (91.1) 4 (50.0) 0.013*
Table 2. Distribution of symptoms related to HP status in dental plaque
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ach – DNA in dental plaque was performed. HP 
infection was established in 36 (62%) of them. A 
combined infection was diagnosed in all of these pa-
tients. Simultaneously, HP infection in the stomach 
and oral cavity has been proven. 10 of them were test-
ed after HP eradication treatment. In 8 of these 10 pa-
tients the result of the HP bacteria test was negative.
The test for HP in dental plaque after eradica-
tion therapy was performed in 35 patients. The re-
sults have been registered in 31 of these patients. In 
18 of them (58%) the result was negative, so in more 
than half of them HP infection was not confirmed. 
Therefore, eradication therapy was fully successful.
There has been accentuated on an eventual 
relation between HP in dental plaque in the context 
of parallel examination with dental and oral status.
From Table 2 it is obvious that the presence of HP 
in dental plaque is in statistically significant relation 
with two symptoms – periodontitis and halitosis. 
Regarding the other symptoms was not established 
such a co-relation, which can be explained with the 
few patients in the group showing negative HP result. 
The most common symptom was the presence 
of bacterial plaque in 97% of all the cases. The next 
were halitosis – in 91.1% and periodontitis – in 82.6% 
of the examined.
In the group of the screening test we inves-
tigated the relation between HP in dental plaque 
and diagnosed upper-dyspeptic syndrome or other 
symptoms.
A statistically significant relation between the 
presence of HP in dental plaque and gastro-duode-
nal syndrome has not been established. At the same 
time no relation was confirmed between HP in den-
tal plaque and anamnestic data for gastro-duodenal 
pathology. The efficiency of eradication therapy was 
estimated on the base of HP status in dental plaque. 
No difference has been established of the effect of 
therapy according to HP presence in dental plaque 
by parallel investigation (р=0.673) (Fig. 1).
Investigation of НР into saliva
35 people were included in the investigation of 
HP-antigen in saliva. HP infection has been diag-
nosed in 18 of them (51.4%). In 11 of the participants 
– 31.4%, examination was performed in patients with 
recurrent HP-infection, proven more than twice. De-
tected HP-infection in 4/11 – 36.3%. HP-infection 
parallel to the syndrome of “burning mouth” was 
established in 9/35 patients – 25.7%. Parallel inves-
tigation in patients with diagnosed HP-infection in 
the stomach, by means of fecal HP antigen test was 
conducted in 15/35 – 42.8%. A combined infection 
affecting stomach and saliva was proven in 5/15 
– 33.3%.
DISCUSSION
On the base of the screening test and parallel in-
vestigation of HP in dental plaque, applying the PCR 
technique, it has been clarified that the frequency of 
HP infection in oral cavity is high, corresponding 
with the rate of this infection in the stomach, rela-
tively 66.7% and 62%. Similar to other authors (7), we 
also established higher frequency in dental plaque, 
but the difference was not significant. These results 
coincide with results by other researchers (4,5,8) and 
we accept the thesis that oral cavity plays the role of 
a primary natural reservoir of infection, facilitating 
its transmission to the stomach. According to Siddiq 
et al. (7) the oral cavity is the initial location of HP 
colonization, from where these bacteria inhabit the 
stomach. Yee et al. have also performed studies con-
cerning HP in dental plaque and established a high 
frequency of the infection, similar to our results. Ap-
plying a PCR method, Panov (9,10) has proved the 
presence of HP bacteria in oral cavity, amounting to 
3% into saliva. The detection of HP in the oral cavity, 
precisely into dental plaque, is often associated with 
poor periodontal health, deep periodontal pockets 
and halitosis. Krasteva et al. (11) concluded in a study 
that 90% of investigated patients with halitosis com-
plaints suffered from disturbances into the oral cav-
ity. The rest 10% of the participants were with diag-
Figure 1. Relative portion of НР eradication depending on 
the presence of HP in dental plaque
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34 
Scripta Scientifica Medicinae Dentalis, vol. 1, №2, 2015, pp. 30-35 
Copyright © Medical University of Varna
nosed systemic disorders. There were confirmed IgG 
antibodies to Helicobacter pylori in 35% of the in-
vestigated. In the group of 56 controls with record-
ed gastric symptoms the rate of H. Pylori infection 
amounted to 27%. 
These statements motivate us to draw attention 
of dental specialists to respect the mandatory testing 
of dental plaque for HP infection, as well as urgent 
recovery of proper oral-dental health status. In this 
context, the topical application of a probiotic con-
taining Lactobacillus reuteri (Bio Gaia pro dentis), 
with confirmed effect upon НР bacteria in vitro, will 
enhance the process of elimination of the bacterium, 
resulting in rehabilitation of the oral cavity and its 
structures. Taking into consideration our previous 
research (1), the results consequent on application of 
sequential eradication therapy in combination with 
probiotic Bio Gaiа are quite acceptable. Boyanova et 
al. (12) investigated and established the effect of in-
hibition of medicines containing Lactobacilli, which 
suppress the growth and decrease the urease activity 
of HP bacteria in vitro. 
Panov et al. (13) detected an oral Helicobacter 
pylori species characterized by resistance to metroni-
dazole and clarithromycin. This confirmed that anti-
biotic resistant Helicobacter pylori species can be reg-
istered in the oral cavity of patients suffering from 
chronic dental and gastro-duodenal diseases even in 
child’s age.
We have established the distribution of com-
bined HP infection affecting simultaneously the 
stomach and dental plaque amounting to 62% of all 
examined. Other authors (4,8) have established a 
combined infection in almost 50% of all investigated 
cases. The diagnosed by us combined, simultaneously 
persisting infection in more than half of the examined 
patients, serves as a confirmation of the thesis that the 
oral cavity is a reservoir from which the HP infection 
is transfered to the stomach, becoming a source of 
re-infection and recurrence concerning also patients 
without any symptoms and complaints. We have es-
tablished a co-relation between the presence of HP 
in the stomach (by urease test, histological examina-
tion, PCR technic) and the oral cavity similar to oth-
er authors (14). These results lead to the conclusion 
that procedures of control upon dental plaque will 
have as a consequence reduction of the frequency of 
re-infection. Krasteva et al. (15) have accentuated on 
the contribution of dentists for overcoming the risk 
of H. pylori infection and re-infection. The fact that 
dental practitioners themselves can be in an explic-
it risk for Helicobacter pylori infection cannot be ne-
glected. Related to this, we advise our patients to vis-
it regularly dental specialists for the purpose of thor-
ough and complex prophylactic cares and adequate 
treatment of the oral cavity. Although it seems logi-
cal to expect successful eradication therapy provided 
for patients with absence of HP bacteria in the oral 
cavity, our results have stressed on the fact that the 
presence of HP in the oral cavity does not influence 
the efficiency of the eradication therapy. The rate of 
success of eradication concerning the oral cavity has 
been established to be similar in HP positive and HP 
negative patients.
Z Ou et al. consider examination of HP infec-
tion with PCR in gastric bioptat as a more appropri-
ate method of diagnostics compared to routine his-
tological, rapid urease and urea breath tests. The 
same test has been applied for proving HP in dental 
plaque and is as reliable as the respiratory test with 
С13 urea. Most of the researchers (3, 6, 16) estimate 
PCR approach as the most sensitive, specific and pre-
cise method for the diagnosis of HP bacteria in the 
oral cavity. Although being labor- and efforts-con-
suming, we highly value this method because of its 
certain and reliable results.
On the base of attained results we can conclude:
 ❖ Oral cavity is the prime reservoir of HP bacteria 
and serves as a source of gastric infecting.
 ❖ A combined, synchronic HP infection affecting 
oral cavity and gastric is often co- existing.
 ❖ Poor oral health status (manifested by peri-
odontitis and halitosis) is accompanied with 
HP infection in the oral cavity.
In CONCLUSION, examination of the oral 
cavity for proving HP bacteria can be useful for 
detection of gastric infection, successful therapeu-
tic influence and prevention of recurrence or re-
infection, as well as adequate treatment of oral cavity 
alterations with proper oral health care. The elimina-
tion of the oral cavity reservoir of Helicobacter pylori 
infection results in a significant success concerning 
H. pylori stomach eradication.
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